Showing 1-10 of 10 results
Health Lab
The newest version of the heparin reversal drug, described in a recent issue of Advanced Healthcare Materials, adjusted the number of protons bound to it, making the molecule less positive so it would preferentially bind to the highly negative heparin, resulting in a much safer drug.
Health Lab
A JAMA viewpoint outlines the tragic story of Shandra Eisenga, a patient who received spine surgery for back pain only to inexplicably contract tuberculosis.
Health Lab
The FDA approved the use of a therapeutic device invented and developed at the University of Michigan for use in children with acute kidney injury and sepsis or a septic condition requiring continuous kidney replacement therapy.
Health Lab
Measles: 10 things to know about immunization and prevention
News Release
Through a $4.17M NIH grant, a team of biomedical engineers, medical clinicians and data scientists from the Max Harry Weil Institute for Critical Care Research and Innovation is collaboratively researching ways to develop a portable, non-invasive breathalyzer-type device and corresponding algorithm to quickly and accurately diagnose acute respiratory distress syndrome (ARDS).
Health Lab
Focusing on the ‘tripledemic’ of RSV, flu and COVID-19 infections that occurred last year, their results underscore the importance of all types of hospital emergency departments being prepared to care for sick children, especially when health systems become strained.
Health Lab
Winter surges in infectious diseases can ruin holidays, but vaccination against COVID-19, flu, RSV, whooping cough and pneumonia can help.
Health Lab
Michigan Medicine researchers have found that growing bacteria on agar mixed with organs is an efficient and effective way to study infectious pathogens.
Health Lab
Research published from experts at Michigan Medicine, the University of Pittsburgh School of Medicine, and UPMC Children’s Hospital of Pittsburgh shows that children in daycare centers were not significant spreaders of COVID-19
Health Lab
A cost effectiveness analysis of the updated COVID-19 vaccine shows that it will save money in older adults and give good value for other adults.